	US 12,257,274 B2
	Fructophilic lactic acid producing bacteria
Muhammed Majeed, Bangalore (IN); Kalyanam Nagabhushanam, East Windsor, NJ (US); Kirankumar Beede, Bangalore (IN); and Sivakumar Arumugam, Bangalore (IN)
Assigned to Sami-Sabinsa Group Limited, Bangalore (IN)
Filed by Muhammed Majeed, Bangalore (IN); Kalyanam Nagabhushanam, East Windsor, NJ (US); Kirankumar Beede, Bangalore (IN); and Sivakumar Arumugam, Bangalore (IN)
Filed on Nov. 8, 2021, as Appl. No. 17/521,383.
Application 17/521,383 is a continuation in part of application No. 16/410,054, filed on May 13, 2019, granted, now 11,197,898.
Prior Publication US 2022/0118032 A1, Apr. 21, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 35/741 (2015.01); A61K 9/20 (2006.01); C12N 1/20 (2006.01); C12P 7/56 (2006.01); C12Q 1/689 (2018.01); C12R 1/07 (2006.01)

CPC A61K 35/741 (2013.01) [A61K 9/2054 (2013.01); C12N 1/205 (2021.05); C12P 7/56 (2013.01); C12Q 1/689 (2013.01); C12R 2001/07 (2021.05)]

7 Claims

1. A fructophilic probiotic bacteria Bacillus coagulans MTCC 25235, isolated from honey, wherein the said bacteria is present in the form of an inoculum, freeze-dried powder, fine powder, tablet, capsule, suspension, solution, emulsion, gummy, chewable or edible foods and administered along with accepted excipients, adjuvants, bioavailability enhancers.